The Vascular Care Group Enrolls Nation's First Patient in FORTAVENA Post-Market Study

The Vascular Care Group (TVCG) announced that its Darien, Connecticut vascular center has enrolled the first patient in the nation in the FORTAVENA Post-Market Study, formally titled "The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study." The...

  General   Sep 25, 2026   0   12  Add to Reading List
The Vascular Care Group Enrolls Nation's First Patient in FORTAVENA Post-Market Study












The Vascular Care Group (TVCG) announced that its Darien, Connecticut vascular center has enrolled the first patient in the nation in the FORTAVENA Post-Market Study, formally titled "The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study." The...
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow